标题
Prognosis of Myelodysplastic Syndromes
作者
关键词
-
出版物
Hematology-American Society of Hematology Education Program
Volume 2010, Issue 1, Pages 330-337
出版商
American Society of Hematology
发表日期
2011-01-17
DOI
10.1182/asheducation-2010.1.330
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia
- (2010) J Boultwood et al. LEUKEMIA
- Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine
- (2010) W. Blum et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies
- (2009) O. Abdel-Wahab et al. BLOOD
- TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)
- (2009) O. Kosmider et al. BLOOD
- Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms
- (2009) A. M. Jankowska et al. BLOOD
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
- (2009) J. W. Vardiman et al. BLOOD
- MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation
- (2009) M. E. Figueroa et al. BLOOD
- Mutations of polycomb-associated geneASXL1in myelodysplastic syndromes and chronic myelomonocytic leukaemia
- (2009) Véronique Gelsi-Boyer et al. BRITISH JOURNAL OF HAEMATOLOGY
- The heterogeneous prognosis of patients with myelodysplastic syndrome and chromosome 5 abnormalities
- (2009) Hagop Kantarjian et al. CANCER
- TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia
- (2009) O. Kosmider et al. HAEMATOLOGICA
- Mutations of E3 Ubiquitin Ligase Cbl Family Members Constitute a Novel Common Pathogenic Lesion in Myeloid Malignancies
- (2009) Hideki Makishima et al. JOURNAL OF CLINICAL ONCOLOGY
- Novel TET2 Mutations Associated With UPD4q24 in Myelodysplastic Syndrome
- (2009) Azim M. Mohamedali et al. JOURNAL OF CLINICAL ONCOLOGY
- DNA Methylation Predicts Survival and Response to Therapy in Patients With Myelodysplastic Syndromes
- (2009) Lanlan Shen et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
- (2009) Pierre Fenaux et al. LANCET ONCOLOGY
- Altered naive and memory CD4+ T-cell homeostasis and immunosenescence characterize younger patients with myelodysplastic syndrome
- (2009) J X Zou et al. LEUKEMIA
- Accurate detection of uniparental disomy and microdeletions by SNP array analysis in myelodysplastic syndromes with normal cytogenetics
- (2009) S Heinrichs et al. LEUKEMIA
- Comorbidities and survival in a large cohort of patients with newly diagnosed myelodysplastic syndromes
- (2009) Rong Wang et al. LEUKEMIA RESEARCH
- Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms
- (2009) Masashi Sanada et al. NATURE
- Acquired mutations in TET2 are common in myelodysplastic syndromes
- (2009) Saskia M C Langemeijer et al. NATURE GENETICS
- Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype
- (2009) Daniel T Starczynowski et al. NATURE MEDICINE
- Mutation inTET2in Myeloid Cancers
- (2009) François Delhommeau et al. NEW ENGLAND JOURNAL OF MEDICINE
- A critical role for phosphatase haplodeficiency in the selective suppression of deletion 5q MDS by lenalidomide
- (2009) S. Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
- (2009) M. Tahiliani et al. SCIENCE
- Whole genome scanning as a cytogenetic tool in hematologic malignancies
- (2008) J. P. Maciejewski et al. BLOOD
- Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs
- (2008) D. E. Rollison et al. BLOOD
- Aberrant DNA methylation is a dominant mechanism in MDS progression to AML
- (2008) Y. Jiang et al. BLOOD
- Molecular pathways in myelodysplastic syndromes and acute myeloid leukemia: relationships and distinctions-a review
- (2008) Paolo Bernasconi BRITISH JOURNAL OF HAEMATOLOGY
- Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System
- (2008) Hagop Kantarjian et al. CANCER
- 250K Single Nucleotide Polymorphism Array Karyotyping Identifies Acquired Uniparental Disomy and Homozygous Mutations, Including Novel Missense Substitutions of c-Cbl, in Myeloid Malignancies
- (2008) A. J. Dunbar et al. CANCER RESEARCH
- Clinical Relevance of Bone Marrow Fibrosis and CD34-Positive Cell Clusters in Primary Myelodysplastic Syndromes
- (2008) Matteo Giovanni Della Porta et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of RPS14 as a 5q- syndrome gene by RNA interference screen
- (2008) Benjamin L. Ebert et al. NATURE
- An Erythroid Differentiation Signature Predicts Response to Lenalidomide in Myelodysplastic Syndrome
- (2008) Benjamin L Ebert et al. PLOS MEDICINE
- Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML)
- (2007) P.W. Wijermans et al. LEUKEMIA RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started